Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Apr 13. pii: ERJ-00214-2016. doi: 10.1183/13993003.00214-2016. [Epub ahead of print]

PMID:
27076583
2.

Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease.

Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Ward B, Teixeira V, Gratziou C, Migliori GB.

Eur Respir J. 2016 May;47(5):1345-1347. doi: 10.1183/13993003.00377-2016. Epub 2016 Mar 23. No abstract available.

PMID:
27009169
3.

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Sotgiu G, D'Ambrosio L, Centis R, Tiberi S, Esposito S, Dore S, Spanevello A, Migliori GB.

Int J Mol Sci. 2016 Mar 12;17(3). pii: E373. doi: 10.3390/ijms17030373. Review.

4.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Payen MC, Sotgiu G, D'Ambrosio L, Alarcon Guizado V, Alffenaar JW, Abdo Arbex M, Caminero JA, Centis R, De Lorenzo S, Gaga M, Gualano G, Roby Arias AJ, Scardigli A, Skrahina A, Solovic I, Sulis G, Tadolini M, Akkerman OW, Alarcon Arrascue E, Aleska A, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Apr;47(4):1235-43. doi: 10.1183/13993003.02146-2015. Epub 2016 Mar 10.

PMID:
26965290
5.

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Arbex MA, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Clin Infect Dis. 2016 May 1;62(9):1188-90. doi: 10.1093/cid/ciw088. Epub 2016 Feb 16. No abstract available.

PMID:
26908794
6.

Cameroon's multidrug-resistant tuberculosis treatment programme jeopardised by cross-border migration.

Matteelli A, Lönnroth K, Mosca D, Getahun H, Centis R, D'Ambrosio L, Jaramillo E, Migliori GB, Raviglione MC.

Eur Respir J. 2016 Feb;47(2):686-8. doi: 10.1183/13993003.01597-2015. No abstract available.

PMID:
26828059
7.

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

Pontali E, Sotgiu G, D'Ambrosio L, Centis R, Migliori GB.

Eur Respir J. 2016 Feb;47(2):394-402. doi: 10.1183/13993003.01891-2015. No abstract available.

PMID:
26828052
8.

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis.

Fox GJ, Mitnick CD, Benedetti A, Chan ED, Becerra M, Chiang CY, Keshavjee S, Koh WJ, Shiraishi Y, Viiklepp P, Yim JJ, Pasvol G, Robert J, Shim TS, Shin SS, Menzies D; Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB.

Clin Infect Dis. 2016 Apr 1;62(7):887-95. doi: 10.1093/cid/ciw002. Epub 2016 Jan 12.

PMID:
26757804
9.

Tuberculosis management and determinants of recurrence.

Sotgiu G, Centis R, Migliori GB.

Int J Tuberc Lung Dis. 2016 Jan;20(1):3. doi: 10.5588/ijtld.15.0900. No abstract available.

PMID:
26688522
10.

Accelerating tuberculosis elimination in low-incidence settings: the role of genomics.

Sotgiu G, Cirillo DM, Miotto P, Centis R, Migliori GB.

Eur Respir J. 2015 Dec;46(6):1841-3. doi: 10.1183/13993003.01664-2015. No abstract available.

PMID:
26621890
11.

Monitoring predictors of mortality: A necessary action to reach TB elimination.

Pontali E, Centis R, D'Ambrosio L, Migliori GB.

Rev Port Pneumol (2006). 2015 Nov 13. pii: S2173-5115(15)00187-6. doi: 10.1016/j.rppnen.2015.10.007. [Epub ahead of print] No abstract available.

PMID:
26590095
12.

Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.

Tiberi S, D'Ambrosio L, De Lorenzo S, Viggiani P, Centis R, Sotgiu G, Alffenaar JW, Migliori GB.

Eur Respir J. 2016 Jan;47(1):333-6. doi: 10.1183/13993003.01278-2015. Epub 2015 Nov 19. No abstract available.

PMID:
26585427
13.

The multidrug-resistant tuberculosis threat: old problems and new solutions.

Sotgiu G, D'Ambrosio L, Centis R, Mura I, Castiglia P, Spanevello A, Migliori GB.

J Thorac Dis. 2015 Sep;7(9):E354-60. doi: 10.3978/j.issn.2072-1439.2015.09.21. No abstract available.

14.

Tuberculosis elimination, patients' lives and rational use of new drugs: revisited.

Tiberi S, D'Ambrosio L, De Lorenzo S, Viggiani P, Centis R, Migliori GB.

Eur Respir J. 2016 Feb;47(2):664-7. doi: 10.1183/13993003.01297-2015. Epub 2015 Nov 5. No abstract available.

PMID:
26541536
15.

Management of drug resistantTB in patients with HIV co-infection.

Pontali E, Sotgiu G, Centis R, D'Ambrosio L, Spanevello A, Migliori GB.

Expert Opin Pharmacother. 2015;16(18):2737-50. doi: 10.1517/14656566.2015.1100169. Epub 2015 Oct 19.

PMID:
26478945
16.

Compassionate and optimum use of new tuberculosis drugs.

Matteelli A, D'Ambrosio L, Centis R, Tadolini M, Migliori GB.

Lancet Infect Dis. 2015 Oct;15(10):1131-2. doi: 10.1016/S1473-3099(15)00296-0. Epub 2015 Sep 20. No abstract available.

PMID:
26461941
17.

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.

Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D'Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S102-18. doi: 10.1093/cid/civ609.

PMID:
26409271
18.

A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium.

D'Ambrosio L, Tadolini M, Centis R, Migliori GB.

J Thorac Dis. 2015 Jul;7(7):1080-5. doi: 10.3978/j.issn.2072-1439.2015.07.15. No abstract available.

19.

How to manage neonatal tuberculosis.

Di Comite A, Esposito S, Villani A, Stronati M; Italian Pediatric TB Study Group.

J Perinatol. 2016 Feb;36(2):80-5. doi: 10.1038/jp.2015.99. Epub 2015 Aug 13.

PMID:
26270256
20.

Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy.

Gillini L, Centis R, D'Ambrosio L, Fedele A, Aprile V, Pasanisi G, Donateo L, Costa D, Migliori GB, Tundo P.

Eur Respir J. 2015 Jul;46(1):274-7. doi: 10.1183/09031936.00012715. Epub 2015 May 28. No abstract available.

PMID:
26022956
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk